Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Vaccine

• Publication date

  2003-09-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0264-410X(03)00427-4PMID 12922080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice

  2002cited by this paper
• A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants.

  2002cited by this paper
• Oral Tolerance Induction in Dermatophagoides pteronyssinus-Sensitized Mice Induces Inhibition of IgE Response and Upregulation of TGF-β Secretion

  2001cited by this paper
• Oral tolerance induction in dermatophagoides pteronyssinus-sensitized mice induces inhibition of IgE response and upregulation of TGF-beta secretion.

  2001cited by this paper
• Intraepithelial lymphocytes: exploring the Third Way in immunology

  2001cited by this paper
• Leishmaniasis: Current Status of Vaccine Development

  2001cited by this paper
• Interleukin‐10‐secreting Peyer's patch cells are responsible for active suppression in low‐dose oral tolerance

  2001cited by this paper
• M. Bagot, N. Terki, S. Bacha, D. Moyse, C. Suck, J. Revuz : « Désensibilisation per os dans l'eczéma de contact au nickel : étude clinico-biologique en double insu contre placebo »

  2000cited by this paper
• gd T cells as mediators of mucosal tolerance: the autoimmune diabetes model

  2000cited by this paper
• Gamma delta T cells as mediators of mucosal tolerance: the autoimmune diabetes model.

  2000cited by this paper
• Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniasis in Colombia: a randomized controlled trial.

  2000cited by this paper
• Immunomodulation of experimental autoimmune diseases via oral tolerance.

  2000cited by this paper
• [Per os desensitization in nickel contact eczema: a double-blind placebo-controlled clinico-biological study].

  1999cited by this paper
• Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.

  1999cited by this paper
• Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis.

  1999cited by this paper
• Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis.

  1999cited by this paper
• CD4+ T Cells Which React to the Leishmania major LACK Antigen Rapidly Secrete Interleukin-4 and Are Detrimental to the Host in Resistant B10.D2 Mice

  1999cited by this paper
• Mucosal immunity and tolerance: relevance to vaccine development

  1999cited by this paper
• Oral tolerance and anti-pathological vaccines.

  1999cited by this paper
• Selective tolerization of Th1‐like cells after nasal administration of a cholera toxoid‐LACK conjugate

  1998cited by this paper
• Gammadelta T cells are not essential for control of cutaneous Leishmania major infection in genetically resistant C57BL/6 mice.

  1997cited by this paper
• βδ T Cells Are Not Essential for Control of Cutaneous Leishmania major Infection in Genetically Resistant C57BL/6 Mice

  1997cited by this paper
• Resistance to Leishmania major Induced by Tolerance to a Single Antigen

  1996cited by this paper
• A subset of γδ T‐cell receptor‐positive cells produce T‐helper type‐2 cytokines and regulate mouse skin graft rejection following portal venous pretransplant preimmunization

  1996cited by this paper
• Tropical disease research: progress 1975-94; highlights 1993-94. Twelfth programme report of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR).

  1995cited by this paper
• Protection against Leishmania major infection in genetically susceptible BALB/c mice by gp63 delivered orally in attenuated Salmonella typhimurium (AroA- AroD-).

  1995cited by this paper
• Intravenous injection of irradiated Leishmania major into susceptible BALB/c mice: immunization or protective tolerance.

  1994cited by this paper
• A role for gamma delta + T cells during experimental infection of mice with Leishmania major.

  1993cited by this paper
• Gamma/Delta T Cells

  1993cited by this paper
• Gamma/delta cells.

  1993cited by this paper
• Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis

  1993cited by this paper
• Vaccination of humans against cutaneous leishmaniasis: cellular and humoral immune responses

  1990cited by this paper
• Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies.

  1988cited by this paper
• Prophylactic immunization against experimental leishmaniasis. VI. Comparison of protective and disease-promoting T cells.

  1987cited by this paper
• The regulation of immune responses to dietary protein antigens.

  1987cited by this paper
• Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis

  1987cited by this paper
• Irradiated mice lose the capacity to 'process' fed antigen for systemic tolerance of delayed-type hypersensitivity.

  1987cited by this paper
• Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection.

  1985cited by this paper
• Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.

  1984cited by this paper
• Immunological responses to fed protein antigens in mice. II. Oral tolerance for CMI is due to activation of cyclophosphamide-sensitive cells by gut-processed antigen.

  1983cited by this paper
• Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection.

  1982cited by this paper

• Efficacy of LaAg Vaccine Associated with Saponin Against Leishmania amazonensis Infection

  2025influential citation
• INTRANASAL DELIVERY OF LaAg VACCINE IMPROVES IMMUNITY OF AGED MICE AGAINST VISCERAL LEISHMANIASIS.

  2024cites this paper
• IL-17A/IFN-γ producing γδ T cell functional dichotomy impacts cutaneous leishmaniasis in mice

  2024influential citation
• Identification of Immunodominant Proteins of the Leishmania (Viannia) naiffi SubProteome as Pan-Specific Vaccine Targets against Leishmaniasis

  2023cites this paper
• The Use of an Adjuvant System Improves Innate and Adaptive Immune Response When Associated with a Leishmania (Viannia) braziliensis Antigen in a Vaccine Candidate against L. (Leishmania) infantum Infection

  2023cites this paper
• Crosslinked chitosan microparticles as a safe and efficient DNA carrier for intranasal vaccination against cutaneous leishmaniasis.

  2023cites this paper
• Rectal Administration of Leishmania Cells Elicits a Specific, Th1-Associated IgG2a Response in Mice: New Perspectives for Mucosal Vaccination against Leishmaniasis, after the Repurposing of a Study on an Anti-Viral Vaccine Candidate

  2023cites this paper
• Emerging role of γδ T cells in protozoan infection and their potential clinical application.

  2022cites this paper
• Inoculation of the Leishmania infantum HSP70-II Null Mutant Induces Long-Term Protection against L. amazonensis Infection in BALB/c Mice

  2021cites this paper
• High-dimensional single cell mass cytometry analysis of the murine hematopoietic system reveals signatures induced by ageing and physiological pathogen challenges

  2021cites this paper
• Nanoencapsulated retinoic acid as a safe tolerogenic adjuvant for intranasal vaccination against cutaneous leishmaniasis.

  2019cites this paper
• The role of TLR9 on Leishmania amazonensis infection and its influence on intranasal LaAg vaccine efficacy

  2019cites this paper
• Pam3CSK4 adjuvant given intranasally boosts anti-Leishmania immunogenicity but not protective immune responses conferred by LaAg vaccine against visceral leishmaniasis.

  2019cites this paper
• Emerging role of γδ T cells in vaccine‐mediated protection from infectious diseases

  2019cites this paper
• Avaliação da eficácia e imunogenicidade de extratos antigênicos homólogos e heterólogos como vacinas contra leishmaniose cutânea murina causada por Leishmania amazonensis

  2018cites this paper
• Intranasal but not subcutaneous vaccination with LaAg allows rapid expansion of protective immunity against cutaneous leishmaniasis.

  2018cites this paper
• Intranasal vaccination with adjuvant-free S. aureus antigens effectively protects mice against experimental sepsis.

  2016cites this paper
• Intranasal vaccination with killed Leishmania amazonensis promastigotes antigen (LaAg) associated with CAF01 adjuvant induces partial protection in BALB/c mice challenged with Leishmania (infantum) chagasi.

  2015cites this paper
• Intranasal Vaccination with Leishmanial Antigens Protects Golden Hamsters (Mesocricetus auratus) Against Leishmania (Viannia) braziliensis Infection

  2015cites this paper
• Short report Open Access

  2015cites this paper
• Intranasal vaccination with extracellular serine proteases of Leishmania amazonensis confers protective immunity to BALB/c mice against infection

  2014cites this paper
• Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis

  2014cites this paper
• A mucosa nasal como uma via estratégica de vacinação contra infecção por Leishmania (Viannia) braziliensis no modelo hamster dourado (Mesocricetus auratus)

  2014influential citation
• Short-term protection conferred by Leishvacin® against experimental Leishmania amazonensis infection in C57BL/6 mice.

  2014cites this paper
• Peripheral expression of LACK-mRNA induced by intranasal vaccination with PCI-NEO-LACK defines the protection duration against murine visceral leishmaniasis

  2012cites this paper
• Chemotactic and Inflammatory Responses in the Liver and Brain Are Associated with Pathogenesis of Rift Valley Fever Virus Infection in the Mouse

  2012cites this paper
• VACINAS:: PROGRESSOS E NOVOS DESAFIOS PARA O CONTROLE DE DOENÇAS IMUNOPREVENÍVEIS

  2011cites this paper
• Studies on Immunology of Leishmania Mexicana

  2010cites this paper
• Intranasal immunization with Leish-111f induces IFN-gamma production and protects mice from Leishmania major infection.

  2010cites this paper
• A Pilot Study of Interferon-γ–Induced Specific Oral Tolerance Induction (ISOTI) for Immunoglobulin E–Mediated Anaphylactic Food Allergy

  2009cites this paper
• Evaluation of the adjuvanticity of artemisinin with soluble Leishmania major antigens in BALB/c mice

  2009cites this paper
• Clinical evaluation of highly pathogenic tick‐borne flavivirus infection in the mouse model

  2009cites this paper
• Differential effects of age on circulating and splenic leukocyte populations in C57BL/6 and BALB/c male mice

  2008cites this paper
• Alternate vehicles for diagnostic patch testing: an update.

  2008cites this paper
• Interferon-gamma is required for the late but not early control of Leishmania amazonensis infection in C57Bl/6 mice.

  2007cites this paper
• Intranasal delivery of naked DNA encoding the LACK antigen leads to protective immunity against visceral leishmaniasis in mice.

  2007cites this paper
• Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan.

  2007cites this paper
• Leukotrienes Are Essential for the Control of Leishmania amazonensis Infection and Contribute to Strain Variation in Susceptibility1

  2006cites this paper
• Hyperbaric oxygen therapy reduces the size of Leishmania amazonensis-induced soft tissue lesions in mice.

  2006cites this paper
• Soluble factors from Leishmania major-specific CD4+T cells and B cells limit L. amazonensis amastigote survival within infected macrophages.

  2006cites this paper
• ESTUDO DO USO DA RADIAÇÃO IONIZANTE COMO FERRAMENTA DE SELEÇÃO DE FORMAS PROMASTIGOTAS METACÍCLICAS DE Leishmania amazonensis , E A INDUÇÃO DE RESPOSTA IMUNOLÓGICA EM MODELOS EXPERIMENTAIS.

  2006cites this paper
• Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis.

  2006cites this paper
• Leishmania amazonensis and macrophage interactions: immune factors necessary to kill the parasite

  2005cites this paper
• Adjuvant effect of Taenia crassiceps glycans against leishmanial antigens in mice infected with Leishmania mexicana.

  2005cites this paper
• TGF-beta-associated enhanced susceptibility to leishmaniasis following intramuscular vaccination of mice with Leishmania amazonensis antigens.

  2005cites this paper
• Intranasal Vaccination against Cutaneous Leishmaniasis with a Particulated Leishmanial Antigen or DNA Encoding LACK

  2004cites this paper
• Molecular and immunological characterization of L14 ribosomal protein from Leishmania braziliensis

  2004cites this paper
• The impaired Th1 immune response of C3HeB/FeJ mice infected with Leishmania amazonensis: lessons learned from immunotherapy and vaccines

  2004cites this paper
• Leishmaniose tegumentar americana: histórico, epidemiologia e perspectivas de controle

  2004cites this paper
• Immunization of Balb/C Mice by Protein Fragments of Lizard Leishmania promastigote

  2004cites this paper
• Fractionation of Lizard Leishmania promastigote Protein

  2004cites this paper
• Protection of C3HeB/FeJ mice against Leishmania amazonensis challenge after previous Leishmania major infection.

  2004cites this paper
• CD4+ Th1 Cells Induced by Dendritic Cell-Based Immunotherapy in Mice Chronically Infected with Leishmania amazonensis Do Not Promote Healing

  2004cites this paper